India China Pharma Deals to Reshape API Economics
India China Pharma Deals: How They Could Reshape India’s API Economics India’s pharmaceutical relationship with China in 2026 is playing out on two very different fronts at once and buyers sourcing API from India should understand both. On one side, Indian pharmaceutical companies are increasingly partnering with Chinese drugmakers to license innovative oncology and specialty […]
Iguratimod API Rheumatoid Arthritis: Mechanism Overview
Iguratimod API for Rheumatoid Arthritis: Mechanism and Formulation Overview Rheumatoid arthritis treatment has increasingly moved toward combination strategies, and Iguratimod has carved out a specific role in that shift — not typically as a first-line monotherapy, but as an add-on option for patients who haven’t achieved adequate control with methotrexate alone. For formulators evaluating this […]
Iguratimod API Manufacturer India: Direct Factory Sourcing
Iguratimod API Manufacturer in India – Direct Factory Sourcing Iguratimod is gaining ground as a treatment option for rheumatoid arthritis, particularly as an add-on therapy for patients who don’t achieve adequate results from methotrexate alone. As demand for this molecule grows alongside rising global autoimmune disease prevalence, more formulators are evaluating Iguratimod API sourcing for […]
Silodosin API BPH Formulations: Manufacturer Overview
Silodosin API for BPH Formulations: Manufacturer Overview Benign prostatic hyperplasia (BPH) remains one of the most common urological conditions formulators develop products for, and Silodosin has carved out a distinct position in that space thanks to its unusually high receptor selectivity. As the molecule moves further into its post-patent generic era, more formulators are evaluating […]
FDA Warning Letter API Contamination: Buyer Lessons
What a Recent FDA Contamination Warning Letter Teaches Buyers About API Supplier Vetting In September 2026, the FDA issued a warning letter to an Indian active pharmaceutical ingredient manufacturer citing lax contamination controls a reminder that GMP compliance failures aren’t rare, isolated events, but a real and ongoing risk across the API supply chain. For […]
Silodosin IH vs JP Grade: Which Does Your Market Need?
Silodosin IH vs JP Grade: Which Does Your Market Require? Silodosin API is commonly offered in two grade specifications IH and JP and buyers new to sourcing this particular molecule often aren’t sure which one their formulation actually needs. Unlike the more familiar IP/BP/EP/USP grade system used across many other APIs, Silodosin’s grading reflects something […]
Silodosin API Manufacturer India: Direct Factory Sourcing
Silodosin API Manufacturer in India – Direct Factory Sourcing Silodosin has moved firmly into its post-patent generic era, and with the global BPH therapeutics market projected to exceed $4.5 billion by 2027, demand for reliable, well-documented API supply has grown right alongside it. If you’re searching for a Silodosin API manufacturer in India, the same […]
Pharmaceutical Intermediates Bulk Pricing & MOQ Guide 2026
Pharmaceutical Intermediates Bulk Pricing & MOQ Guide 2026 Unlike finished APIs, where pricing tends to be relatively transparent and quoted consistently across buyers, pharmaceutical intermediates pricing can vary more noticeably depending on purity requirements, order volume, and where in the synthesis chain the intermediate sits. Buyers sourcing intermediates for the first time are often surprised […]
Why WHO-GMP Certification Matters Most in Semi-Regulated Markets
Why WHO-GMP Certification Matters Most in Semi-Regulated Markets Not all “GMP certified” claims carry the same regulatory weight and which certification actually matters most depends heavily on where your finished product is headed. For buyers and formulators operating in semi-regulated markets, WHO-GMP certification isn’t just one credential among several equally valid options. In many of […]